Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...

Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...

LOS ANGELES, January 21, 2025--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing therapies to surmount current cancer drug resistance ...

Real Madrid head coach Carlo Ancelotti will make some interesting changes to the starting line up ... [+] when it comes to hosting Celta Vigo in the Copa del Rey last 16 on Thursday. Real Madrid ...

DUBAI, Jan 16 (Reuters) - The ceasefire in Gaza represents a "great victory" for the Palestinian resistance, Iran's Revolutionary Guards said on Thursday, warning against any possible breach by ...

This investigational treatment is intended for adults with locally advanced or metastatic EGFR-mutated non–small cell lung ... DXd with or without osimertinib in untreated patients with advanced ...

"Acquired resistance to front-line therapies and, ultimately, disease progression are unfortunate realities for most patients with advanced EGFR-mutated non-small cell lung cancer. This Priority ...

Burchett, along with several other GOP hardliners, are drawing a clear red line when it comes to Trump’s first big policy package. They say the measure — which is expected to include a raise ...